R-roscovitine - Revision history

imported>Xenbase: /* Description */

2019-09-12T12:27:42Z

Description

← Older revision		Revision as of 12:27, 12 September 2019
Line 1:		Line 1:
	==Description==		==Description==
	"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."		"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."

	Source: Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733		Source: Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733

imported>Xenbase at 12:27, 12 September 2019

2019-09-12T12:27:31Z

← Older revision		Revision as of 12:27, 12 September 2019
Line 1:		Line 1:
	==Description==		==Description==
	"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."		"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."
			Source: Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733
	Source:

	Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733


	~~[[File:Olomoucine.png\|frame\|right\|Olomoucine structure, photo from Sigma-Aldrich]]~~

imported>Xenbase: Created page with "==Description== "R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines,..."

2019-09-12T12:26:01Z

Created page with "==Description== "R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines,..."

New page

==Description==
"R-roscovitine is a cyclin-dependent kinase (CDK) inhibitor that induces apoptosis in colorectal, breast, prostate, multiple myeloma, other cancer cell lines, and tumor xenografts, in micromolar concentrations. R-roscovitine also blocks voltage-gated K+channels by binding to the open state." "R-roscovitine inhibits open hERG channels but does not become trapped in the pore."

Source:

Cernuda B, Fernandes CT, Allam SM, Orzillo M, Suppa G, Chia Chang Z, et al. (2019) The molecular determinants of R-roscovitine block of hERG channels. PLoS ONE 14(9): e0217733. https://doi.org/10.1371/journal.pone.0217733

[[File:Olomoucine.png|frame|right|Olomoucine structure, photo from Sigma-Aldrich]]